CryoPort Cash Flow Statement
NASDAQ: CYRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
CryoPort free cash flow
In fiscal 2025, CryoPort generated -$8.6 million of operating cash flow and spent $16.4 million on capital expenditures. That left free cash flow of -$25.0 million, a free-cash-flow margin of -14.2% of revenue. CryoPort returned $10.0 million to shareholders through share repurchases.
Summary generated from market data by MetaCap's automated system. Methodology
CryoPort cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20202021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 78.30M | -114.76M | -99.59M | -37.33M | -275.53M | -32.69M | -18.33M | -9.56M | -7.90M | -13.11M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 27.71M | 30.76M | 27.49M | 22.77M | 20.25M | 9.87M | 2.42M | 857.94K | 664.83K | 374.20K |
| Stock-Based Compensation | 10.07M | 16.57M | 19.82M | 20.08M | 15.35M | 8.92M | 16.52M | 5.48M | 3.55M | 3.12M |
| Change in Working Capital | -4.51M | 848.00K | -519.00K | -22.82M | -3.22M | -2.26M | 53.00K | 56.40K | -163.54K | -21.53K |
| Operating Cash Flow | -8.58M | -16.32M | -757.00K | -1.85M | 8.13M | -14.87M | -1.32M | -3.35M | -3.58M | -5.72M |
| Capital Expenditures | -16.44M | -17.25M | -38.78M | -22.11M | -23.88M | -8.92M | -5.34M | -2.91M | -1.71M | -1.06M |
| Investing Cash Flow | 250.32M | 176.81M | 36.05M | -59.68M | -469.25M | -382.31M | -62.93M | -12.88M | -1.80M | -1.07M |
| Share Repurchases | -10.01M | — | — | -37.96M | 0 | 0 | — | — | — | — |
| Debt Repaid | — | -163.77M | -25.00M | — | — | — | — | — | — | — |
| Financing Cash Flow | -21.07M | -161.53M | -23.80M | -39.17M | 564.34M | 385.58M | 74.15M | 38.53M | 15.90M | 6.06M |
| Net Change in Cash | 205.21M | -1.06M | 9.75M | -102.51M | 102.23M | -10.36M | 9.91M | 22.28M | 10.52M | -722.90K |
| Free Cash Flow | -25.02M | -33.58M | -39.54M | -23.96M | -15.76M | -23.78M | -6.66M | -6.27M | -5.30M | -6.78M |
This table shows 10 annual periods of CryoPort's cash flow statement, from FY 2025 back to FY 2016, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow CYRX's reporting calendar. What is a cash flow statement?